SUPLASYN

This brand name is authorized in Ecuador, Tunisia, South Africa

Active ingredients

The drug SUPLASYN contains one active pharmaceutical ingredient (API):

1 Hyaluronate sodium
UNII YSE9PPT4TH - HYALURONATE SODIUM
Read about Hyaluronate sodium

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SUPLASYN Solution for injection Web Search MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D03AX05 Hyaluronic acid D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03A Cicatrizants → D03AX Other cicatrizants
Discover more medicines within D03AX05
S01KA01 Hyaluronic acid S Sensory organs → S01 Ophthalmologicals → S01K Surgical aids → S01KA Viscoelastic substances
Discover more medicines within S01KA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria Identifier(s): 6431-MEE-0721, 6432-MEE-0721
Country: TN Direction de la Pharmacie et du Mรฉdicament Identifier(s): 10783011
Country: ZA Health Products Regulatory Authority Identifier(s): A39/3.2/0352

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.